When was Oakbio founded?

Oakbio was founded in 2011 and raised its 1st funding round 3 years after it was founded.

Where is Oakbio located?

Oakbio is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California.

How many employees does Oakbio have?

As of Apr 30, 2026, the latest employee count at Oakbio is 1.

Is Oakbio a funded company?

Oakbio is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 21, 2014.

When was the latest funding round of Oakbio?

Oakbio's latest funding was a $***** Grant (prize money) round on Apr 30, 2017, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does Oakbio rank among its competitors?

Oakbio ranks 1824th amongst 1951 active competitors, of which 450 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was LifeMine Therapeutics, which secured $75M in Aug, 2026.

Who are the top competitors of Oakbio?

Oakbio's top competitors include Antheia, Transcenta and Akeso. Among them, LifeMine Therapeutics secured the most recent funding round in August, 2026.

Oakbio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Oakbio is a Carbon Capture and Utilization company that uses engineered microbes to convert streams of waste carbon into high-value products. The company has developed a proprietary platform that can convert CO2 from flue gas and other carbon sources into chemical feedstocks, biofuels, PHA bioplastics, and animal feed. The conversion is carried out by the company's proprietary microbes whose combinations and proportions in the bioreactor also determine the end product. The company's major product is biobutanol, which it produces from flue gas and is 87 octane fuel compatible. Apart from this the company also produces bioplastics and various other products from waste carbons.

Website: oakbio.com
Social
Email ID: *****@oakbio.com
Registered Address: Sunnyvale, California

Key Metrics

Founded Year

2011

Location

Sunnyvale, United States

Stage

Deadpooled

Latest Funding Round

Grant (prize money), Apr 30, 2017, $*****

Investors

EIC Fund & 1 more

Ranked

1824^th among 1951 active competitors

Employee Count

1 as on Apr 30, 2026

Similar Companies

Antheia & 2659 more

View Oakbio's full profile

Oakbio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Oakbio Inc CIN: 264686607 , United States, Active	Dec 26, 999	-	16 (As on Dec 31, 2024)	-

Oakbio has raised funding over 2 rounds. Its first funding round was on Apr 21, 2014. Its latest funding round was a Grant (prize money) round on Apr 30, 2017 for $*****. 1 investor participated in its latest round. Oakbio has 2 institutional investors.

Here is the list of recent funding rounds of Oakbio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 30, 2017	4365395	Grant (prize money)	2061287	7161249	5320698	9268987
Apr 21, 2014	5088181	Grant (prize money)	6246815	4946738	8965545	ERA

Access funding benchmarks and valuations. Sign up today!

View details of Oakbio's funding rounds and investors

The founders of Oakbio is Brian Sefton.

Here are the details of Oakbio's key team members:

Brian Sefton: Founder & CEO & CTO of Oakbio.

View details of Oakbio's Founder profiles and Board Members

Oakbio's employee count trend

Oakbio has 1 employees as of Apr 26. Here is Oakbio's employee count trend over the years:

Uncover Oakbio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Oakbio include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Oakbio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
2nd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
3rd	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
4th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
5th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
6th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
7th	LifeMine Therapeutics 2016, Watertown (United States), Series E	Developer of novel drugs from fungi via genome mining and recombinant overexpression	$563M	Fidelity Investments, 6 Dimensions Capital ... & 17 others	63/100
8th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$364M	Maverick Ventures, SoftBank Vision Fund & 16 others	62/100
9th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	62/100
10th	Avalyn Pharma 2011, Seattle (United States), Public	Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis	$389M	Perceptive Advisors, Norwest & 22 others	61/100
1824th	Oakbio 2011, Sunnyvale (United States), Deadpooled	Converting waste into biofuels using engineered microbes	-	EIC Fund, ERA	20/100